152 related articles for article (PubMed ID: 28504924)
1. mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.
Zafari V; Hashemzadeh S; Hosseinpour Feizi M; Pouladi N; Rostami Zadeh L; Sakhinia E
Bosn J Basic Med Sci; 2017 Aug; 17(3):255-261. PubMed ID: 28504924
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
Panza A; Votino C; Gentile A; Valvano MR; Colangelo T; Pancione M; Micale L; Merla G; Andriulli A; Sabatino L; Vinciguerra M; Prattichizzo C; Mazzoccoli G; Colantuoni V; Piepoli A
Biochim Biophys Acta; 2014 Jun; 1843(6):1225-36. PubMed ID: 24631504
[TBL] [Abstract][Full Text] [Related]
3. A key regulatory role of the transcription factor NFATc2 in bronchial adenocarcinoma via CD8+ T lymphocytes.
Maxeiner JH; Karwot R; Sauer K; Scholtes P; Boross I; Koslowski M; Türeci O; Wiewrodt R; Neurath MF; Lehr HA; Finotto S
Cancer Res; 2009 Apr; 69(7):3069-76. PubMed ID: 19318584
[TBL] [Abstract][Full Text] [Related]
4. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
[TBL] [Abstract][Full Text] [Related]
5. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
Pancione M; Sabatino L; Fucci A; Carafa V; Nebbioso A; Forte N; Febbraro A; Parente D; Ambrosino C; Normanno N; Altucci L; Colantuoni V
PLoS One; 2010 Dec; 5(12):e14229. PubMed ID: 21151932
[TBL] [Abstract][Full Text] [Related]
7. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
8. PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil.
Schöckel L; Woischke C; Surendran SA; Michl M; Schiergens T; Hölscher A; Glass F; Kreissl P; Klauschen F; Günther M; Ormanns S; Neumann J
BMC Cancer; 2024 Feb; 24(1):234. PubMed ID: 38378472
[TBL] [Abstract][Full Text] [Related]
9. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
10. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
[TBL] [Abstract][Full Text] [Related]
11. The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.
Delage B; Rullier A; Capdepont M; Rullier E; Cassand P
Nutr J; 2007 Sep; 6():20. PubMed ID: 17767717
[TBL] [Abstract][Full Text] [Related]
12. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
[TBL] [Abstract][Full Text] [Related]
13. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Park HK; Kim H; Kim HG; Cho YM; Jung WY; Han HS; Hwang TS; Kwon GY; Lim SD
J Korean Med Sci; 2015 May; 30(5):533-41. PubMed ID: 25931782
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Expression Levels of NFATc2 and PPARG Genes Two Effector Elements of WNT Pathway in Non-Small Cell Lung Carcinoma.
Motamediyan K; Zafari V; Bornehdeli S; Caner A; Asadi M; Hashemzadeh S; Firozi MR; Raeisi M
Adv Biomed Res; 2023; 12():184. PubMed ID: 37694246
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.
Blitek A; Szymanska M
Theriogenology; 2017 Oct; 101():53-61. PubMed ID: 28708516
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of caveolin-1 in Apc(min/+) mice promotes colorectal tumorigenesis.
Friedrich T; Richter B; Gaiser T; Weiss C; Janssen KP; Einwächter H; Schmid RM; Ebert MP; Burgermeister E
Carcinogenesis; 2013 Sep; 34(9):2109-18. PubMed ID: 23640045
[TBL] [Abstract][Full Text] [Related]
19. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
Zhang Y; Yu J; Lee C; Xu B; Sartor MA; Koenig RJ
Oncotarget; 2015 Dec; 6(38):40418-32. PubMed ID: 26595524
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
Hawcroft G; Gardner SH; Hull MA
J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
